Immunogenicity and Safety of Fractional Booster Dose of Sanofi Pasteur's Inactivated Poliomyelitis Vaccine (IMOVAX Polio) Administered Intradermally Versus Full Booster Dose of Inactivated Poliomyelitis Vaccine (IMOVAX Polio) Administered Intramuscularly at 15 to 18 Months of Age in Healthy Toddlers in The Philippines.
Latest Information Update: 01 May 2016
At a glance
- Drugs Poliovirus vaccine (Primary)
- Indications Poliomyelitis
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sanofi; Sanofi Pasteur
- 23 Mar 2010 Actual patient number (225) added as reported by ClinicalTrials.gov.
- 23 Mar 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 23 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.